thalidomide has been researched along with leupeptins in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dagvadorj, J; Hassan, F; I-E-Khuda, I; Islam, S; Koide, N; Naiki, Y; Noman, AS; Tumurkhuu, G; Yokochi, T; Yoshida, T | 1 |
Gütschow, M; Kehm, H; Krönke, J; Lindner, S; Mangold, M; Steinebach, C | 1 |
2 other study(ies) available for thalidomide and leupeptins
Article | Year |
---|---|
Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression.
Topics: Animals; Cell Line; Cells, Cultured; Cysteine Proteinase Inhibitors; Down-Regulation; I-kappa B Proteins; Immunosuppressive Agents; Interleukin-1 Receptor-Associated Kinases; JNK Mitogen-Activated Protein Kinases; Leupeptins; Lipopolysaccharide Receptors; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins c-akt; Thalidomide; TNF Receptor-Associated Factor 6; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2009 |
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs.
Topics: Adaptor Proteins, Signal Transducing; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Cell Survival; Humans; Leupeptins; Multiple Myeloma; Protein Multimerization; Proteolysis; Proton Magnetic Resonance Spectroscopy; Thalidomide; Ubiquitin-Protein Ligases | 2019 |